[NICE Guideline] Delirium: prevention, diagnosis and management Clinical guideline [CG103]

NICE | March 2019 | Delirium: prevention, diagnosis and management Clinical guideline [CG103]

NICE has updated this clinical guideline, the guideline covers diagnosing and treating delirium in people aged 18 and over in hospital and in long-term residential care or a nursing home. It also covers identifying people at risk of developing delirium in these settings and preventing onset. It aims to improve diagnosis of delirium and reduce hospital stays and complications.

In March 2019 NICE removed the use of olanzapine for the treatment of delirium in people who are distressed or considered a risk to themselves or others.

Full details from NICE 

Summary of key recommendations from NICE guidance

The latest edition of the NICE Bites newsletter provides a useful summary of the latest NICE guideline on the subject of dementia, which was released in June 2018.

NICE Bites is a monthly prescribing bulletin published by North West Medicines Information centre which summarises key recommendations from NICE guidance. NICE Bites No 111 October 2018 includes one topic: Dementia; assessment, management and support for people living with dementia and their carers. Sections covered include: diagnosis, review after diagnosis, involving people in decision-making, providing information, pharmacological treatment, managing non-cognitive symptoms, assessing and managing co-morbidities, risks during hospital admission, palliative care.

Full reference: Dementia; Assessment, Management and Support for People Living With Dementia and Their Carers (NICE Bites)

Full guideline: Dementia: assessment, management and support for people living with dementia and their carers – guidance (NG97)  | National Institute for Health and Care Excellence (NICE) | June 2018.

Dementia (update): Topic engagement [NICE]

NICE | September 2018 | Dementia (update)

NICE want to hear about the 5 key areas for quality improvement which you consider as having the greatest potential to improve the quality of care in this area. Tell NICE about the 5 key areas for quality improvement which you consider as having the greatest potential to improve the quality of care in this area (NICE).

See NICE for details

NICE guidelines recommend telling people about dementia research opportunities

NIHR | June 2018 | New NICE guidelines recommend telling people about dementia research opportunities

NICE recently advised that every patient diagnosed with dementia should be provided with information of research opportunities they could potentially participate in.

 

volunteer-2055015_1920.png

NIHR  New NICE guidelines recommend telling people about dementia research opportunities

 

 

Updated NICE guidance

The National Institute for Health and Care Excellence (NICE) have updated their guidance on the management and support of dementia.  This is the first time the guideline has been updated in 10 years, and acts as a reference for best practice for all those working in the health and social care field, including GPs, and social workers.

A NICE spokesman said the key changes are the recommendations around training staff correctly and those to help carers to better support people living with dementia.

It also recommends providing people living with dementia with a single named health or social care professional who is responsible for coordinating their care.

The updated guidance also recommends that the initial assessment includes taking a history (including cognitive, behavioural and psychological symptoms, and the impact symptoms have on their daily life) from the person with suspected dementia, and if possible, from someone who knows the person well.

Full guideline: Dementia: assessment, management and support for people living with dementia and their carers (NG97)

See also: New NICE guidelines recommend telling people about dementia research opportunities

 

NICE takes key role in new European project for faster access to Alzheimer’s disease drugs

Patients’ priorities will be brought to the fore in new Alzheimer’s project | NICE

road-259815_960_720.jpg

NICE is taking part in a European project to speed up the development of new drugs to treat Alzheimer’s disease.

The ROADMAP initiative aims to establish a sustainable platform for real world evidence generation on Alzheimer’s disease.

The new project provides a unique and game-changing opportunity to gather evidence from other sources, such as electronic health records, and discover what outcomes are important to patients and carers.

Alzheimer’s disease, and the different ways it presents and progresses in different people, poses a difficulty for traditional clinical trials which do not always provide answers decision makers such as NICE would be looking for when assessing new drugs to treat the disease.

Read the full news story here